← Evidence map

ArticleNature communications2022

Low-cost anti-mycobacterial drug discovery using engineered E. coli.

Nadine Bongaerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35798732